![U-50488 hydrochloride | Kappa-opioid agonist | U50488 | U 50488 | CAS [67197-96-0] - [67198-13-4] | Axon 1202 | Axon Ligand™ with >99% purity available from stock from supplier Axon Medchem](https://www.axonmedchem.com/media/catalog/product/cache/1/image/9df78eab33525d08d6e5fb8d27136e95/1/2/1202_144.gif "U-50488 hydrochloride | Kappa-opioid agonist | U50488 | U 50488 | CAS [67197-96-0] - [67198-13-4] | Axon 1202 | Axon Ligand™ with >99% purity available from stock from supplier Axon Medchem")
U-50488 hydrochloride | Kappa-opioid agonist | U50488 | U 50488 | CAS [67197-96-0] - [67198-13-4] | Axon 1202 | Axon Ligand™ with >99% purity available from stock from supplier Axon Medchem
Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatment
The Electric Power Engineering Handbook - Five Volume Set
Plasma Physics and Controlled Nuclear Fusion Research 1992
Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatment
Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatment
Marine Drugs | Free Full-Text | Marine Pharmacology in 2012–2013: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, and Antiviral Activities; Affecting the Immune and Nervous Systems, and ...
SYMPOSIA
Marine Drugs | Free Full-Text | Marine Pharmacology in 2012–2013: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, and Antiviral Activities; Affecting the Immune and Nervous Systems, and ...
Marine Drugs | Free Full-Text | Marine Pharmacology in 2012–2013: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, and Antiviral Activities; Affecting the Immune and Nervous Systems, and ...
Marine Pharmacology in 2012-2013: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms ...
Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatment
Uradni list RS 082/2014, Uredbeni del
![Anti-Kv beta 1/KCNAB1 antibody [OTI9F7] (ab236393) | Abcam](https://www.abcam.com/ps/products/236/ab236393/Images/ab236393-312321-3933.jpg?impolicy=product-thumbnail "Anti-Kv beta 1/KCNAB1 antibody [OTI9F7] (ab236393) | Abcam")
Anti-Kv beta 1/KCNAB1 antibody [OTI9F7] (ab236393) | Abcam
PDF) Perspectives and challenges of antioxidant therapy for atrial fibrillation
Oral Presentations From the WORLD CONGRESS OF CARDIOLOGYScientific Sessions 2012
Visualizing_MeSH_Term_Interaction_Over_Time/terms.txt at master · NCBI-Hackathons/Visualizing_MeSH_Term_Interaction_Over_Time · GitHub
Untitled
Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatment
Marine Drugs | Free Full-Text | Marine Pharmacology in 2012–2013: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, and Antiviral Activities; Affecting the Immune and Nervous Systems, and ...
Visit our Expo - Redox and Inflammation signaling 2012
Binghe Wang, Page 1 Curriculum Vitae Binghe Wang Georgia State University Current position: Regents' Professor of Chemistry a
